August 11, 2026 05:19 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Jharkhand student protest turns tense: Water cannons, lathicharge after Assembly march barricades breached | ‘Mother tongue is as pure as one's mother’: Vijay-led Tamil Nadu government makes Tamil Thaai Vazhthu mandatory in big language push | Indian envoy Kwatra cites US, UK laws to counter ‘myths’ around FCRA Bill | Jharkhand students march to assembly today: JPSC row escalates despite govt action | ‘A morning I will cherish’: Raghav Chadha meets PM Modi, shares photos from ‘enriching’ meeting | Delhi Mercedes crash kills 70-year-old woman: Cop’s son behind wheel, beer bottle found | Indian-origin woman accused of ‘visa fraud’ on X: US Attorney steps in with major clarification | US Senate passes Russia sanctions bill: India can face Trump’s 100% tariff threat | Expired meat, rotten vegetables found at Bengaluru's luxury hotels, legal action begins | 'I'm ready to be humiliated': Vijay, Udhayanidhi Stalin clash in Tamil Nadu Assembly over Cauvery dispute
Delhi-Covaxin

No Covaxin doses for 18-44 years in Delhi from tomorrow

| @indiablooms | May 13, 2021, at 05:21 am

New Delhi/IBNS: People between the age group of 18-44 years will not get Covaxin doses in Delhi from Thursday as there is no stock of the Bharat Biotech developed vaccine left in the national capital.

The government has urged the central government to ensure uninterrupted supplies of vaccines, adding that Covishield stocks will last nine days.

There are four days of Covaxin left to be administered on frontline workers and those above 45.

The shots are essential for those who received the first dose around four weeks ago.

Earlier, Delhi Deputy Chief Minister Manish Sisodia has hit out at the Centre's vaccine management saying that Covaxin manufacturer Bharat Biotech has refused to supply the vaccine to the national capital.

Sisodia said Bharat Biotech has refused to supply the doses citing directives from the government and limited availability.

"Once again I would say exporting 6.6 crore doses was biggest mistake. We are forced to shut down 100 Covaxin-vaccination sites in 17 schools due to no supply," he wrote.

Sisodia said Delhi has asked for the supply of 1.34 crore doses, equal doses of Bharat Biotech's Covaxin and Serum Institute of India’s Covishield, to vaccinate the 18-44 age group.

Delhi entered the fourth week of lockdown on Monday, with stricter restrictions this time including the shutdown of the metro.

The national capital reported 13,287 new coronavirus cases and 300 more fatalities on Wednesday, while the positivity rate came down to 17 per cent.

India is currently reeling under the second wave of COVID-19 infections with around 3.5 lakh cases and 4,000 deaths being reported daily.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.